Reviewed & approved by Dr. Nova Reyes · Last checked 2026-10-25. ← Back to Evidence Library
Testagen: what the evidence says
At a glance
What it is: a synthetic short peptide (Lys-Glu-Asp-Gly, "KEDG") from V. Kh. Khavinson's "peptide bioregulator" program in St. Petersburg, promoted for testicular and hormonal health (vendor claim) Unknown. In PubMed the KEDG sequence appears as a peptide based on anterior pituitary extract, not under the name Testagen; the link between the name and testicular effects comes from sellers. Unknown
What the evidence says: no human trials found. The only biological studies of this sequence are in hypophysectomized birds (birds with the pituitary gland surgically removed) (thyroid and thymus effects). None tested testicular function. R1, R2
Biggest risks: unknown. No human safety data were found. Unknown Gray-market vials add quality risks.
Rating
| Human Human evidence | No human data |
| Animal Animal / lab evidence | Reported: bird studies of thyroid and thymus only R1, R2 |
| Regulatory | Not FDA-approved (no Drugs@FDA record) · Russia: registration status UNVERIFIED · WADA 2026: not named; S0 (unapproved substances) likely applies |
| Established human dose | None. Study details lists what studies used where reported |
Evidence verdict: Human: No human data Card verdict: No human data (testicular claims untested; only studied in pituitary-removed birds) Card note: No study found tests the testicular use the product is sold for.
This page reports what studies used. It is not dosing advice.
Legend: HUMAN data · ANIMAL / LAB data · UNKNOWN · UNVERIFIED: not yet confirmed against a primary source
About the evidence (developer-led): most of this literature comes from V. Kh. Khavinson's St. Petersburg Institute of Bioregulation and Gerontology and allied Russian, Ukrainian and Georgian groups. Many papers are short, Russian-language, and not independently repeated. Read the findings as the developers' own reports.
What is it?
Testagen is a 4-amino-acid peptide (Lys-Glu-Asp-Gly, "KEDG"). Khavinson's group calls these "tissue-specific bioregulators" and proposes that they act on gene activity in the organ they are named for. R1 That idea is the developers' hypothesis and has not been confirmed independently. Unknown
Does it work?
- Animal Birds: in chickens and hens with the pituitary removed, KEDG reduced thyroid hormone disturbances R1 and affected thymus structure. R2
- Unknown Testosterone or testicular function: no studies found in people or animals. Claims are vendor marketing. Unknown
- Unknown Human clinical trials: none found.
Is it safe?
- Unknown No human safety data found.
- Unknown Long-term effects unknown.
Gray-market "research use only" Testagen: extra risks
Unknown contents. Vials sold online as "research use only" are not made under drug-quality rules, so identity, strength and sterility are unknown. This is a general caution; we have not found independent testing data for this product. Unknown Vendor claims about effects in people are marketing, not evidence. Unknown
What we don't know
- Unknown Whether it does anything in people
- Unknown Whether a short peptide like this survives digestion or reaches tissues when swallowed or injected
- Unknown What is actually in a gray-market vial or capsule labelled "testagen"
- Unknown Whether "Testagen" vials actually contain KEDG
Is it legal?
Not FDA-approved (no Drugs@FDA record, openFDA query Oct 25, 2026). Russia: UNVERIFIED whether registered as a medicine in GRLS or sold only as a supplement. EU, UK, Japan, China: UNVERIFIED not checked against EMA, MHRA, PMDA or NMPA. WADA: not named on the 2026 Prohibited List; S0 bans at all times any substance with no current regulatory approval for human therapeutic use.
Study details
These are amounts researchers used, not recommendations.
R1 Animal Animal: thyroid in hypophysectomized birds (birds with the pituitary gland surgically removed) (Kuznik 2011)
| Study | People / model | Route | Amount used | Follow-up | Reported | Side effects / limitations | Citation |
|---|---|---|---|---|---|---|---|
| Kuznik 2011 | Hypophysectomized chickens and old hens | Not in abstract | Not in abstract | 40 days | Less thyroid disturbance | Animal | PMID 22268052 |
R2 Animal Animal: thymus in hypophysectomized birds (birds with the pituitary gland surgically removed) (Pateyk 2013)
Full reference list (PubMed entries checked Oct 25, 2026)
- Kuznik BI, et al. Bull Exp Biol Med. 2011;150(4):495-9. PMID 22268052
- Pateyk AV, et al. Bull Exp Biol Med. 2013. PMID 23658898
Disclaimer
This page is for education and harm reduction, not medical advice or a recommendation to use Testagen. Talk to a clinician you trust before using any drug, and report problems to FDA MedWatch (https://www.fda.gov/safety/medwatch).
Approved for Adam Greene by Dr. Nova Reyes, 2026-10-25.